Mastering Clinical Trials: A Comprehensive Guide

This course offers a comprehensive exploration of the critical early stages of clinical trials, focusing on Phase 0 and Phase 1. You’ll gain a deep understanding of how drug safety and efficacy are evaluated before a treatment progresses to larger-scale studies. We’ll delve into the process of microdosing in Phase 0 trials and its significance in determining the pharmacokinetics, or how the drug is absorbed, distributed, metabolized, and eliminated by the body. You’ll also learn about the principles of pharmacodynamics, which explain how a drug produces its effects, and how both of these key areas inform the design of future trials.

Additionally, this course covers the essential safety protocols in Phase 1 trials, including how adverse events are monitored and how the maximum tolerated dose is determined. You'll understand the importance of preclinical animal studies, including the role of toxicity testing and safety assessments, which set the stage for human testing. Through real-world examples and case studies, you’ll see how clinical research organizations, sponsors, and regulatory bodies collaborate to ensure patient safety and regulatory compliance.

By the end of this course, you will have the knowledge and practical insights needed to navigate the complexities of early-phase clinical trials. Whether you are new to clinical research or looking to enhance your expertise, this course will provide you with the foundational skills to thrive in drug development and contribute to bringing new treatments to market.

COURSE UPDATE — OCTOBER 2026: Now expanded to over 8 hours of video, including two brand-new sections — Decentralized and Hybrid Clinical Trials, and Clinical Trial Careers — with matching course notes for every new lecture.